Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Astex Pharmaceuticals presents novel anticancer compounds

Nov. 30, 2011

French researchers patent novel kinase inhibitors

Nov. 30, 2011

Scientists at Karus Therapeutics prepare new PI3K inhibitors

Nov. 30, 2011

Data presented from phase I trial of OPB-31121 in advanced solid malignancies

Nov. 30, 2011

DMC recommends to continue Celsion's phase III HEAT study

Nov. 29, 2011

FDA gives clearance for phase IIa study of AEZS-130

Nov. 29, 2011

Exelixis signs CRADA for cabozantinib with National Cancer Institute

Nov. 29, 2011

Roche synthesizes new Mdm2 inhibitors

Nov. 29, 2011

Novel tumor-specific promoters designed by Korean team

Nov. 29, 2011

Yakult gains approval for use of Elplat in new indication in Japan

Nov. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...